Skip to content

Septerna, Inc. SEPN Operating Cash Flow

Operating Cash Flow at other companies

Amgen logo
AmgenAMGN
$2.19B+57.4%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-$60.58M-146%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
-$13.06M+35.5%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
-$71.91M-17.7%
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
-$17M+86.3%
Precigen logo
PrecigenPGEN
-$43.83M-168%

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.65B+319%
Enterprise value$1.6B+1,325%
P/S22.8×-379×

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Reported directly by Septerna, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Septerna, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Septerna, Inc.'s operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Septerna, Inc.'s operating cash flow?
Septerna, Inc. (SEPN) reported operating cash flow of -$25.63M in Q1 2026.
How has Septerna, Inc.'s operating cash flow changed year-over-year?
Septerna, Inc.'s operating cash flow decreased by 9.8% year-over-year, from -$23.34M to -$25.63M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.